HOME › DRUGS › SITAGLIPTIN PHOSPHATE
ACTIVE SUBSTANCE / INN

SITAGLIPTIN PHOSPHATE

Brand name(s): SITAGLIPTIN, SITAGLIPTIN PHOSPHATE; METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE AND SITAGLIPTIN PHOSPHATE, JUVISYNC, SITAGLIPTIN PHOSPHATE, JANUVIA, SITAGLIPTIN AND METFORMIN HYDROCHLORIDE, STEGLUJAN
FDA LISTED
PRESCRIPTION
DISCONTINUED
NONE (TENTATIVE APPROVAL)
ANDA204144
ANDA216086
ACTIVE SUBSTANCE
Sitagliptin Phosphate
REGULATORS
FDA
SPONSORS / MAH
SANDOZ, ZYDUS PHARMS USA INC, PH HEALTH
TOTAL APPLICATIONS
10
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
STEGLUJANNDA209805MSD SUB MERCKPrescription
JANUVIANDA021995MERCK SHARP DOHMEPrescription
JUVISYNCNDA202343MERCK SHARP DOHMEDiscontinued
SITAGLIPTIN PHOSPHATEANDA202387SANDOZPrescription
SITAGLIPTIN PHOSPHATEANDA208186ZYDUS PHARMS USA INCNone (Tentative Approval)
SITAGLIPTINANDA216086MSN LABORATORIES PRIVATE LTDNone (Tentative Approval)
SITAGLIPTIN AND METFORMIN HYDROCHLORIDEANDA202388SANDOZPrescription
SITAGLIPTIN AND METFORMIN HYDROCHLORIDEANDA204144PH HEALTHDiscontinued
METFORMIN HYDROCHLORIDE AND SITAGLIPTIN PHOSPHATEANDA208535ZYDUS PHARMS USA INCNone (Tentative Approval)
SITAGLIPTIN PHOSPHATE; METFORMIN HYDROCHLORIDEANDA202365WATSON LABS INCNone (Tentative Approval)

FULL INTELLIGENCE ON SITAGLIPTIN PHOSPHATE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →